Article
Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance
10 Apr 2014
Abstract excerpt
BACKGROUND: Disseminated cutaneous malignant melanoma (CMM) is commonly unresponsive to standard chemotherapies, and there are as yet no predictive markers of therapy response. METHODS: In the present study we collected fresh-frozen pretreatment lymph-node metastasis samples (n=14) from melanoma patients with differential response to dacarbazine (DTIC) or temozolomide (TMZ) chemotherapy, to identify proteins with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
